164
Views
6
CrossRef citations to date
0
Altmetric
NANOTECHNOLOGY

Properties of a Graphene Oxide-Balofloxacin Composite and Its Effect on Bacteriostasis

, , &
Pages 2279-2289 | Received 18 Jan 2013, Accepted 06 Apr 2013, Published online: 05 Sep 2013
 

Abstract

A novel graphene oxide-balofloxacin nanocomposite was synthesized, and the loading and release behavior of fluorescent antibacterial balofloxacin on graphene oxide was investigated. The surface morphologies of the nanocomposite were evaluated using transmission electron microscopy and fluorescence microscopy, and the amount of balofloxacin loaded on graphene oxide reached 160.3 mg/g at the initial balofloxacin concentration of 8.51 µg/ml. The graphene oxide and balofloxacin nanocomposite showed the advantage of a longer release time than many current developed nanoscaled drug carriers, which was probably due to the hydrogen bonding interaction between graphene oxide and balofloxacin. The study of the release liquid of e. coli in vitro bacteriostasis suggests that the graphene oxide-balofloxacin nanocomposite has a superior effect against e. coli.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (grant Nos. 21275059 and 21175049), the Fundamental Research Funds for the Central Universities (NO.JB-ZR1118 and 1215), and the Natural Science Foundation of Fujian Province, (grant No. 2011J01044).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.